- Home
- BEATW vs FBIOP Comparison
BEATW vs FBIOP Comparison
Compare BEATW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- FBIOP
- Stock Information
- Founded
- BEATW 2015
- FBIOP N/A
- Country
- BEATW United States
- FBIOP United States
- Employees
- BEATW N/A
- FBIOP 186
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- BEATW Technology
- FBIOP Health Care
- Exchange
- BEATW Nasdaq
- FBIOP Nasdaq
- Market Cap
- BEATW N/A
- FBIOP N/A
- IPO Year
- BEATW N/A
- FBIOP N/A
- Fundamental
- Price
- BEATW $0.57
- FBIOP $6.04
- Analyst Decision
- BEATW
- FBIOP
- Analyst Count
- BEATW 0
- FBIOP 0
- Target Price
- BEATW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- BEATW 4.7K
- FBIOP N/A
- Earning Date
- BEATW 03-14-2025
- FBIOP N/A
- Dividend Yield
- BEATW N/A
- FBIOP N/A
- EPS Growth
- BEATW N/A
- FBIOP N/A
- EPS
- BEATW N/A
- FBIOP N/A
- Revenue
- BEATW N/A
- FBIOP N/A
- Revenue This Year
- BEATW N/A
- FBIOP N/A
- Revenue Next Year
- BEATW N/A
- FBIOP N/A
- P/E Ratio
- BEATW N/A
- FBIOP N/A
- Revenue Growth
- BEATW N/A
- FBIOP N/A
- 52 Week Low
- BEATW $0.50
- FBIOP N/A
- 52 Week High
- BEATW $0.62
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- FBIOP 35.35
- Support Level
- BEATW N/A
- FBIOP $6.22
- Resistance Level
- BEATW N/A
- FBIOP $6.53
- Average True Range (ATR)
- BEATW 0.00
- FBIOP 0.29
- MACD
- BEATW 0.00
- FBIOP -0.06
- Stochastic Oscillator
- BEATW 0.00
- FBIOP 14.00
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.